Ifacin Capsule

About Ifacin 150 mg Capsule

Ifacin is a brand of rifampicin, an anti-tubercular antibiotic used in the treatment of tuberculosis and certain other bacterial infections. It is available as a 150 mg capsule.

There are 18 brands of Rifampicin listed in Bangladesh. The lowest listed price is Firifam 150 mg Tablet at ৳ 1 per unit.

What is Ifacin 150 mg Capsule?

Ifacin contains rifampicin, an antibiotic that belongs to the anti-tubercular group of medicines. It works by interfering with the bacteria's ability to make proteins, which helps stop their growth. Doctors prescribe it as part of a combination regimen for tuberculosis and for some other specific infections. The medicine is supplied as a 150 mg capsule by Square Pharmaceuticals PLC. Because rifampicin is a prescription-only medicine, it should only be taken under the supervision of a qualified healthcare professional. Always follow your doctor's instructions regarding how and when to take it.

Uses of Ifacin

Ifacin is used in the treatment of tuberculosis, usually as part of a multi-drug regimen. It is also used for the meningococcal carrier state, a condition where a person carries the bacteria that cause meningitis without being ill. Your doctor will determine whether this medicine is appropriate for your specific condition and will decide on the overall treatment plan.

How to use Ifacin

Take Ifacin exactly as prescribed by your doctor. The dose and duration of treatment depend on your individual condition and will be decided by your doctor. Swallow the capsule whole with a full glass of water. Your doctor may advise you to take it at a particular time in relation to meals. Do not change the dose or stop taking the medicine without consulting your doctor, as this can affect the treatment outcome.

Side effects of Ifacin

Like all medicines, Ifacin can cause side effects. Common ones include facial flushing, itching, rash, nausea, vomiting, diarrhoea, and stomach discomfort. It may also cause flu-like symptoms such as fever, chills, headache, and dizziness. A noticeable effect is the orange-red discolouration of urine, faeces, sweat, saliva, tears, and other body fluids; this is expected and usually harmless. Serious side effects are possible, so report any unusual symptoms to your doctor promptly.

Safety and precautions

Before taking Ifacin, tell your doctor if you have liver problems, kidney disease, or any allergies, especially to rifamycins. This medicine can interact with many other drugs, so inform your doctor about all medicines you are taking, including over-the-counter products. It may reduce the effectiveness of oral contraceptives. If you are pregnant or breastfeeding, discuss the risks and benefits with your doctor. Your doctor may monitor your liver function during treatment. Do not start or stop this medicine without medical advice.

Frequently asked questions

How should Ifacin be taken?

The dose and how often you take Ifacin will be decided by your doctor based on your condition. Always follow the prescribed schedule. Swallow the capsule with water. Do not adjust the dose yourself or stop treatment early without consulting your doctor, even if you feel better.

What is Ifacin used for and what kind of medicine is it?

Ifacin is an anti-tubercular antibiotic containing rifampicin. It is used in the treatment of tuberculosis, typically in combination with other medicines, and for the meningococcal carrier state. It works by stopping the growth of certain bacteria. Your doctor will determine if it is suitable for you.

How should Ifacin be stored?

Store Ifacin capsules between 15°C and 30°C. Protect them from excessive heat and light. Keep the medicine out of reach of children. Do not use it after the expiry date printed on the pack. If you have any doubts about storage, ask your pharmacist.

Can Ifacin affect other medicines I take?

Yes, rifampicin can interact with many medicines, including some blood thinners, epilepsy drugs, and antivirals. It may also reduce the effectiveness of oral contraceptives. Always tell your doctor and pharmacist about all medicines you are using before starting Ifacin.

Also available as

450 mg (Capsule)

Indications

In the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type. Bacteriologic cultures should be obtained before the start of therapy to confirm the ... Read moreIn the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type. Bacteriologic cultures should be obtained before the start of therapy to confirm the susceptibility of the organism to rifampinand they should be repeated throughout therapy to monitor the response to treatment. Since resistance can emerge rapidly, susceptibility tests should be performed in the event of persistent positive cultures during the course of treatment. If test results show resistance to rifampin and the patient is not responding to therapy, the drug regimen should be modified.

Pharmacology

Rifampicin suppresses initiation of chain formation for RNA synthesis in susceptible bacteria by binding to the β subunit of DNA-dependent RNA polymerase, thus blocking RNA transcription.

Dosage & Administration

Rifampin can be administered by the oral route or by IV infusion. IV doses are the same as those for oral.

Tuberculosis:
  • Adults: 10 mg/kg, in a single daily administration, not to exceed 600 mg/day, oral or IV
  • Pediatric Patients: 10–20 mg/kg, not to exceed 600 mg/day, oral or IV
It is recommended that oral rifampin be administered once daily, either 1 hour before or 2 hours after a meal with a full glass of water.

Rifampin is indicated in the treatment of all forms of tuberculosis. A three-drug regimen consisting of rifampin, isoniazid, and pyrazinamide is recommended in the initial phase of shortcourse therapy which is usually continued for 2 months. The Advisory Council for the Elimination of Tuberculosis, the American Thoracic Society, and the Centers for Disease Control and Prevention recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid (INH), rifampin and pyrazinamide for initial treatment of tuberculosis unless the likelihood of INH resistance is very low. The need for a fourth drug should be reassessed when the results of susceptibility testing are known. If community rates of INH resistance are currently less than 4%, an initial treatment regimen with less than four drugs may be considered.

Following the initial phase, treatment should be continued with rifampin and isoniazid for at least 4 months. Treatment should be continued for longer if the patient is still sputum or culture positive, if resistant organisms are present, or if the patient is HIV positive.

Interaction

May accelerate the metabolism and reduce the effect of drugs that are metabolised by CYP450 enzymes (e.g. quinidine, phenytoin, theophylline). Decreased concentrations of atovaquone and increased concentrations of rifampicin when taken concomitantly. Concurrent use of ketoconazole and rifampicin may result in decreased serum concentrations of both drugs. May decrease serum concentrations of enalaprilat. Reduced absorption by antacids. Increased risk of hepatotoxicity with halothane or isoniazid.

Contraindications

Rifampicin is contraindicated in patients with a history of hypersensitivity to rifampin or any of the components, or to any of the rifamycins. Rifampin is contraindicated in patients who are also receiving ritonavir-boosted saquinavir due to an increased risk of severe hepatocellular toxicity.

Rifampin is contraindicated in patients who are also receiving atazanavir, darunavir, fosamprenavir, saquinavir, or tipranavir due to the potential of rifampin to substantially decrease plasma concentrations of these antiviral drugs, which may result in loss of antiviral efficacy and/or development of viral resistance.

Side Effects

Facial flushing and itching, with or without a rash, flu-like syndrome characterised by episodes of fever, chills, headache, dizziness, bone pain, shortness of breath, and malaise; GI adverse effects (e.g. nausea, vomiting, anorexia, diarrhoea, epigastric distress), pseudomembranous colitis, eosinophilia, leucopenia, haemolytic anaemia; alterations in kidney function and renal failure, menstrual disturbances, oedema, myopathy, muscular weakness; orange-red discolouration of the urine, faeces, sweat, saliva, sputum, tears, and other body fluids; thrombophlebitis, local irritation and inflammation after prolonged IV infusion. Rarely, eye irritation and visual disturbances, anaphylaxis or shock.

Pregnancy & Lactation

Pregnancy: When administered during the last few weeks of pregnancy, rifampin can cause post natal hemorrhages in the mother and infant for which treatment with vitamin K may be indicated.

Nursing Mothers: Because of the potential for tumorigenicity shown for rifampin in animal studies, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Precautions & Warnings

Rifampicin has been shown to produce liver dysfunction. Fatalities associated with jaundice have occurred in patients with liver disease and in patients taking rifampin with other hepatotoxic agents. Patients with impaired liver function should be given rifampin only in cases of necessity and then with caution and under strict medical supervision. In these patients, careful monitoring of liver function, especially SGPT/ALT and SGOT/AST should be carried out prior to therapy and then every 2 to 4 weeks during therapy. If signs of hepatocellular damage occur, rifampin should be withdrawn.

In some cases, hyperbilirubinemia resulting from competition between rifampin and bilirubin for excretory pathways of the liver at the cell level can occur in the early days of treatment. An isolated report showing a moderate rise in bilirubin and/or transaminase level is not in itself an indication for interrupting treatment; rather, the decision should be made after repeating the tests, noting trends in the levels, and considering them in conjunction with the patient's clinical condition.

Rifampin has enzyme-inducing properties, including induction of delta amino levulinic acid synthetase. Isolated reports have associated porphyria exacerbation with rifampin administration.

Overdose Effects

Nausea, vomiting, abdominal pain, pruritus, headache, and increasing lethargy will probably occur within a short time after ingestion; unconsciousness may occur when there is severe hepatic disease. Transient increases in liver enzymes and/or bilirubin may occur. Brownish-red or orange discoloration of the skin, urine, sweat, saliva, tears, and feces will occur, and its intensity is proportional to the amount ingested.

Liver enlargement, possibly with tenderness, can develop within a few hours after severe overdosage; bilirubin levels may increase and jaundice may develop rapidly. Hepatic involvement may be more marked in patients with prior impairment of hepatic function. Other physical findings remain essentially normal. A direct effect upon the hematopoietic system, electrolyte levels, or acid-base balance is unlikely.

Facial or periorbital edema has also been reported in pediatric patients. Hypotension, sinus tachycardia, ventricular arrhythmias, seizures and cardiac arrest were reported in some fatal cases.

Storage Conditions

Store between 15-30° C. Avoid excessive heat and protect from light.

Alternative brands of Rifampicin

Other brands with the same generic name, cheapest first.

Firifam Tablet

150 mg

Rifampicin

Synovia Pharma PLC.

৳ 0.98 ৳ 1 2% off per unit

Firifam Tablet

450 mg

Rifampicin

Synovia Pharma PLC.

৳ 0.98 ৳ 1 2% off per unit

Rifcin Capsule

150 mg

Rifampicin

Pharmadesh Laboratories Ltd.

৳ 10.81 ৳ 11.03 2% off per unit

Rifatan Syrup

100 mg/5 ml

Rifampicin

G. A. Company Ltd.

৳ 28.8 ৳ 29.39 2% off per unit

Rifcin Syrup

100 mg/5 ml

Rifampicin

Pharmadesh Laboratories Ltd.

৳ 78.4 ৳ 80.00 2% off per unit

See all 18 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.